Almac has launched a range of biomarker solutions specifically designed to meet the needs of the biopharma industry.
The company's solutions are intended to support biopharma companies in adopting biomarker strategies to enable them to better understand their drug, improve their drug's success rate, improve their drug's value and ultimately maximise their drug's potential.
The use of biomarkers can add value to a compound in development and the ability to identify those patients most likely to respond to a therapy increases the chances of success and the licensing potential of the drug.
Biomarkers for biopharma applications include pharmacodynamic solutions, patient selection markers, assay development and bioinformatics/biostatistics consultancy.
